TITLE

Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures

AUTHOR(S)
Elia, Stefano; Massoud, Renato; Guggino, Gianluca; Cristino, Benedetto; Cortese, Claudio; De Massimi, Alessia Raffaella; Zenobi, Rossella
PUB. DATE
April 2008
SOURCE
European Journal of Cardio-Thoracic Surgery;Apr2008, Vol. 33 Issue 4, p723
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Objective: Pleural effusion is a common diagnostic problem and a challenge to the thoracic surgeon. The analysis of serum and body fluids for tumor markers is an established diagnostic procedure. Among various markers, tumors are linked to the overexpression of a glycolytic isoenzyme, M2-pyruvate-kinase (M2-PK). This preliminary study evaluated this enzyme as a tumor marker to differentiate malignant from benign pleural effusion. Methods: The tumor M2-PK concentration was measured in the EDTA-plasma and pleural fluid of 34 patients with an established diagnosis of cancer, either primary of the chest (18) or secondary to chest (16) and in 34 controls with benign effusion. The concentration was quantitatively determined by an enzyme-linked immunosorbent assay. The cut-off level between negative and positive values of the tumor M2-PK was defined as the benign group''s mean+2SD (95% percentile). True-positives, false-positives, true-negatives, and false-negatives, were determined with ‘positive’ referring to histologically proven malignant effusion and ‘negative’ referred to as nonmalignant effusions. Sensitivity, specificity, positive predictive value, and negative predictive value were assessed. Results: The cut-off value was established at 7.61U/ml for plasma and 32.9U/ml for pleural fluid. Both plasma and pleural fluid levels of tumor M2-PK were significantly higher in patients with known chest malignancy, either primary or metastatic, compared to nonmalignant effusions (p <0.001). Sensitivity in pleural fluid was significantly higher compared to plasma (85.7% vs 76.2%; p <0.01). Moreover, negative predictive value was higher for pleural fluid compared to plasma (79.4% vs 70.8; p <0.01) Conclusions: Tumor M2-PK marker is useful in differentiating malignant from benign pleural effusions. Moreover, its sensitivity and NPV in pleural fluid are significantly higher compared to plasma. The usefulness of such a test is not strictly diagnostic but aims at excluding poorly performing patients from further invasive procedures. Thus, the inclusion of M2-PK within a panel of well-known tumor markers such as CEA, MCA, Ca 125 and Ca 19-9, may help in increasing the overall sensitivity and specificity.
ACCESSION #
31304700

 

Related Articles

  • Quinacrine (Atabrine) in the Treatment of Neoplastic Effusions. Dollinger, Malin R.; Krakoff, Irwin H.; Karnofsky, David A. // Annals of Internal Medicine;Feb67, Vol. 66 Issue 2, p249 

    Presents a study which examined the effectiveness of quinacrine treatment of neoplastic effusions in adult patients. Materials and methods; Mechanism of quinacrine; Evaluation of the effects of quinacrine; Results and discussion.

  • Development of subdural effusions in association with pyruvate dehydrogenase deficiency. Raissaki, Maria; Grafakou, Olga; Giannopoulos, Andreas; Spilioti, Martha; Rodenburg, Richard; Smeitink, Jan; Evangeliou, Athanasios; Gourtsoyiannis, Nicholas // European Radiology;Oct2005, Vol. 15 Issue 10, p2205 

    Presents a letter to the editor about the development of subdural effusions in association with pyruvate dehydrogenase deficiency.

  • ThinPrep Cytological Findings of Desmoplastic Small Round Cell Tumor with Extensive Glandular Differentiation: A Case Study. Hyun-Jung Kim; Byeong Seok Sohn; Ji-Eun Kwon; Jeong Yeon Kim; Kyeongmee Park // Korean Journal of Pathology;Apr2013, Vol. 47 Issue 2, p182 

    Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive neoplasm. The cytological diagnosis of this tumor has only been reported in a few cases. In most of these cases, the diagnosis was made using fine-needle aspiration cytology. Most DSRCTs resemble disseminated...

  • Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology. Siyamek Neragi-Miandoab // Supportive Care in Cancer;Dec2008, Vol. 16 Issue 12, p1323 

    Abstract  With an increasing number of cancer survivors, the annual incidence of malignant pleural effusions has been rising in recent decades worldwide. Many patients with various forms of cancer develop malignant pleural effusions at some point in their life. Patients most commonly...

  • Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio). Verma, Akash; Abisheganaden, John; Light, R. // Lung;Feb2016, Vol. 194 Issue 1, p147 

    Aim: We studied the diagnostic potential of serum lactate dehydrogenase (LDH) in malignant pleural effusion. Methods: Retrospective analysis of patients hospitalized with exudative pleural effusion in 2013. Results: Serum LDH and serum LDH: pleural fluid ADA ratio was significantly higher in...

  • Pleuropulmonary Blastoma: A Case Report. Hammad, Abdelmohsen M.; Serag, Amr R.; Bayoumi, Shereif L. // Internet Journal of Thoracic & Cardiovascular Surgery;2003, Vol. 6 Issue 2, p90 

    Pleuropulmonary blastoma (PPB) is a rare and aggressive malignant tumor that affects children. We present a case of pleuropulmonary blastoma in a 16-month-old male baby who was referred to our department due to apparently right side encysted pleural effusion. Chest CT depicted a large cystic...

  • The Occurrence Of Pleural Effusion Secondary To Ovarian Fibroma. Kant, Surya; Verma, Sanjay Kumar; Verma, Rajendra // Internet Journal of Pulmonary Medicine;2009, Vol. 10 Issue 2, p7 

    The association of pleural effusion and ascitis, secondary to ovarian tumor, are considered to be uncommon clinical condition. Hereby we reported a case of 43 years old female presented as right sided pleural effusion and ascitis secondary to ovarian fibroma and after removal of ovarian tumor...

  • Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients. Schaner, Marci E.; Davidson, Ben; Skrede, Martina; Reich, Reuven; Florenes, Vivi Ann; Risberg, Bjorn; Berner, Aasmund; Goldberg, Iris; Givant-Horwitz, Vered; Trope, Claes G.; Kristensen, Gunnar B.; Nesland, Jahn M.; Borresen-Dale, Anne-Lise // Molecular Cancer;2005, Vol. 4, p26 

    Background: While numerous studies have characterized primary ovarian tumors, little information is available regarding expression patterns of metastatic sites of this cancer. To define sets of genes that distinguish primary and metastatic ovarian tumors, we used cDNA microarrays to characterize...

  • Hepatic hydatid cyst rupturing into pericardial cavity. Martin-Herrera, F.; Cruz, I.; Muñuz, L. // Heart;Oct2006, Vol. 92 Issue 10, p1536 

    The article reports on a case of hepatic cyst affecting panel A of the pericardium. Surgical treatment consisted of a partial cystopericystectomy and evacuation of the pericardial effusion containing the daughter cysts in the panels C and D of the pericardium. The patient showed neither clinical...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics